APOE-ɛ4 status and cognitive decline after subthalamic nucleus-deep brain stimulation in Parkinson’s disease: preliminary results of the GENEPARK-DBS study
Objective: The aim of this study was to evaluate wheter the presence of APOE-ε4 in a cohort of Parkinson’s disease (PD) patients treated with subthalamic…An analysis of gender differences in the clinical profile of Parkinson’s Disease patients
Objective: The present study aimed at characterising in depth the overall clinical profile of male and females PD patients. Background: Parkinson Disease (PD) is the…Increased MD and decreased FA reflect cognitive impairment in PSP
Objective: To identify white matter (WM) alterations associated with cognitive impairment in progressive supranuclear palsy (PSP). Background: PSP is accompanied with cognitive impairment [1;2], but…Cognitive underside of Parkinson’s Disease: A working memory updating failure in freezing of gait
Objective: To investigate the role of components of working memory updating in freezing of gait phenomenon Parkinson’s Disease Background: The role of cognitive deficits has…The impact of mild cognitive impairment on functioning in people with Parkinson’s disease
Objective: To understand the experience of mild cognitive impairment (MCI) in people with Parkinson’s disease (PwP) and its impact on daily life. Background: Parkinson’s disease…Nucleus basalis of Meynert and total gray matter atrophy are related to cognitive and gait decline in Parkinson’s disease
Objective: To assess the associations between the nucleus basalis of Meynert (NBM) and total grey matter atrophy with cognitive phenotype and gait measures in a…Narrative review of the efficacy of the efficacy of transcranial magnetic stimulation with patients with Parkinson disease.
Objective: To evaluate the efficacy of transcranial magnetic stimulation with patients with Parkinson diseases. Background: Parkinson's disease is one of the most common causes of…Regional brain volume and cognitive alterations in Huntington’s Disease Patients
Objective: To investigate i) HD patterns of cortical and subcortical atrophies ii) associations between atrophy and clinical, motor and cognitive features. Background: Huntington’s disease (HD)…Cognitive assessment of Parkinson’s disease carriers of the novel p.A30G mutation in the SNCA gene
Objective: The aim of the present report was to evaluate the cognitive profile of symptomatic Parkinson’s disease (PD) patients in a p.A30G SNCA genetic cohort.…Proof-of-concept clinical trial: Prevent cognitive decline in GBA-associated Parkinson’s Disease
Objective: To prevent cognitive decline in GBA-associated Parkinson’s Disease (PD). Background: Dementia represents a key milestone in the course of PD with limited effective treatments…
- « Previous Page
- 1
- …
- 25
- 26
- 27
- 28
- 29
- …
- 128
- Next Page »